Rimonest is primarily an
IP (Intellectual Property) company. We hold the patents to
several pharmacological actions and applications of both aqueous and
oily fractions of pomegranate fruits, individually, and in combination.
Specific synergistic interactions between key pomegranate chemicals,
like punicic acid from the seed oil, and caffeic acid, ellagic acid
and luteolin from the juice and peels, have also been discovered and
protected. We are always interested to speak with potential manufacturers,
distributors and investors.
The patents of Rimonest can be briefly summarized.
The writing in black stands for issued patents, in color, patents
pending.
1. Phytoestrogen supplements. US
5,891,440 (1999), 6,060,063
(2000). Israel 130603 (2004). (Israel
149521, Europe 97950362.0.)
2. Juice and oil products. South Africa 2002/3898,
Australia 774619 (2004). US 10/217430 (2002), 11/028,656 (2005), Europe 00979906.5,
Japan 2001-539462, Israel 149521
3. Pure compounds. PCT (2005).
Registered trademarks in USA:
CardiogranateŽ, EstragranateŽ
The entire portfolio, or IP for specific applications, is available
for licensing. For more information, please contact:
Maurice Hyman, CPA
Rimonest Financial Advisor
finance@rimonest.com
Chaim Crown, JD
Rimonest General Counsel
legal@rimonest.com
|